[1] |
WANG Hao, MA Jinfu, MA Rui, LI Xiaogang, ZHAO Qiang, ZHANG Xian.
One Case of Thrombocytopenia Caused by Cefoperazone Sulbactam Sodium for Injection
[J]. Chinese Journal of Pharmacovigilance, 2025, 22(6): 686-688.
|
[2] |
YU Wenlu, ZHANG Hong.
Research Progress in Applications of Strychnine Semen in Orthopedics and Traumatology
[J]. Chinese Journal of Pharmacovigilance, 2025, 22(1): 116-120.
|
[3] |
LIU Qian, LI Bo, SHU Xinyang.
Lanqin oral liquid combined with antibacterial drugs for the treatment of acute tonsillitis: a systematic review and Meta-analysis
[J]. Chinese Journal of Pharmacovigilance, 2024, 21(8): 916-920.
|
[4] |
YU Xin, GONG Leilei, YAO Weijie, YUAN Sisi, FENG Xin.
Chinese patent medicines for recurrent spontaneous abortion: a scoping review of clinical evidence
[J]. Chinese Journal of Pharmacovigilance, 2024, 21(4): 361-365.
|
[5] |
LI Xingren, SHEN Aizong, SU Dan.
Evaluation of the rationality of proton pump inhibitors in preventing perioperative stress related mucosal disease in biliary and pancreatic surgery
[J]. Chinese Journal of Pharmacovigilance, 2023, 20(9): 1022-1026.
|
[6] |
HUANG Cuili, GAO Ao, WANG Jiaxi, GUO Haili, XU Xiaohan, CHENG Yinchu, GUO Daihong.
Automatic monitoring and assessment of antibiotics-related thrombocytopenia
[J]. Chinese Journal of Pharmacovigilance, 2023, 20(7): 807-811.
|
[7] |
WANG Yu, HUANG Jingyi, HOU Lixin, LI Shuang, CUI Yongkang, HUANG Lanwei.
Humoral immune characteristics of peripheral blood of CAP patients with antibiotic-associated DILI
[J]. Chinese Journal of Pharmacovigilance, 2023, 20(2): 132-135.
|
[8] |
ZHUANG Hongyan, ZANG Yannan, LIU Shanshan, NIU Mengxi, FANG Meng, YIN Dongqing, GUO Wei.
Analysis of neuropsychiatric adverse reactions caused by zolpidem
[J]. Chinese Journal of Pharmacovigilance, 2022, 19(8): 889-892.
|
[9] |
XU Zhe, JU Ping, LUO Qi, YANG Huan, WANG Yang.
930 cases of adverse drug reactions induced by antibacterial drugs in children
[J]. Chinese Journal of Pharmacovigilance, 2022, 19(3): 317-321.
|
[10] |
ZHANG Yongheng, HAN Chen, YANG Xiao, HAN Xiuqi, YUAN Hongchang, DENG Zhijian.
Analysis of 313 Instructions for Injectable Drugs
[J]. Chinese Journal of Pharmacovigilance, 2021, 18(7): 669-673.
|
[11] |
XI Yuling, HUI Hongyan, GUO Xiaohe, DENG Zhijian.
Literature Analysis of Anaphylactic Shock Induced by Reduced Glutathione for Injection
[J]. Chinese Journal of Pharmacovigilance, 2021, 18(7): 674-677.
|
[12] |
LI Yaolei, ZHANG Bing, ZHANG Xiaomeng, LIN Zhijian.
Evaluation and Consideration of Clinical Safety of Traditional Chinese Medicine Based on Toxic Components
[J]. Chinese Journal of Pharmacovigilance, 2021, 18(6): 520-524.
|
[13] |
LI Sheng, ZHENG Lei.
Clinical Use and Safety of Oseltamivir Phosphate
[J]. Chinese Journal of Pharmacovigilance, 2021, 18(3): 250-255.
|
[14] |
CHEN Huanlei, LI Ning, ZHENG Xueling.
112 Cases of Hypersensitivity Induced by Methylprednisolone Sodium Succinate
[J]. Chinese Journal of Pharmacovigilance, 2021, 18(2): 155-159.
|
[15] |
WEI Yuanyuan, LI Fang, TAO Xiaomei, GU Hongyan.
Prevention of Adverse Reactions of Antibiotics in a Respiratory Department
[J]. Chinese Journal of Pharmacovigilance, 2021, 18(11): 1083-1086.
|